Company Filing History:
Years Active: 1981-1983
Title: Oded Awerbuch: Pioneering Innovations in Biological Antioxidants
Introduction
Oded Awerbuch, an accomplished inventor residing in Givatayim, Israel, has made significant contributions to the field of biological chemistry. With a total of two patents to his name, Awerbuch's work primarily focuses on the development of glycoside derivatives and compounds that serve essential roles in promoting growth and protecting vitamin E-deficient animals.
Latest Patents
Awerbuch's latest innovations include two notable patents. The first patent, titled "Glycoside derivatives of 6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline," introduces new glycoside derivatives that are not only biologically effective antioxidants but also serve as protective agents for animals lacking vitamin E. His second patent, "1-Acylethoxyquin compounds and compositions for treating vitamin," details derivatives of ethoxyquin and their applications as active ingredients in pharmaceutical compositions. These compounds exhibit antioxidant properties and demonstrate potential in promoting the growth of vitamin E-deficient animals.
Career Highlights
Oded Awerbuch's career has been marked by significant achievements in the realm of chemical innovation. His dedication to research and development has led to breakthroughs that facilitate advancements in pharmaceutical compositions and biological antioxidants. Awerbuch's contributions underscore his commitment to enhancing animal health and welfare through innovative chemical solutions.
Collaborations
Throughout his career, Awerbuch has collaborated with notable professionals in his field, including Emil Menachemoff and Raphael R Haber. These collaborations have allowed for the exchange of ideas and fostered an environment of innovation, ultimately enhancing the quality and reach of Awerbuch's patents.
Conclusion
Oded Awerbuch stands out as a distinguished inventor whose work in the chemistry of biological antioxidants significantly impacts animal health. With his innovative patents and collaborative efforts, he continues to pave the way for advancements in pharmaceutical compositions, contributing to the well-being of vitamin E-deficient animals and the broader field of biological research.